Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -25.13%866.77M | ---- | 0.36%1.16B | ---- | 22.78%1.15B | ---- | 23.21%939.6M | ---- | 16.93%762.63M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -32.99%-41.29M | ---- | -13.17%-31.05M | ---- | -70.25%-27.44M | ---- | -46.98%-16.12M | ---- | -14.15%-10.96M |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---28.52M | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | 6.24%-177.66M | ---- | -10.73%-189.48M | ---- | -12.20%-171.12M | ---- | -33.46%-152.51M | ---- | 25.94%-114.28M |
| Impairment and provisions: | ---- | 739.11%15.34M | ---- | -95.18%1.83M | ---- | 237.78%37.96M | ---- | -172.51%-27.55M | ---- | -6.32%38M |
| -Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | ---- | --39.14M | ---- | ---- | ---- | --23.43M |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.67M |
| -Impairment of trade receivables (reversal) | ---- | -61.60%702K | ---- | --1.83M | ---- | ---- | ---- | 17.34%-5.49M | ---- | -465.82%-6.64M |
| -Other impairments and provisions | ---- | --14.64M | ---- | ---- | ---- | 94.65%-1.18M | ---- | -225.83%-22.07M | ---- | -54.74%17.54M |
| Revaluation surplus: | ---- | -11,210.42%-16.29M | ---- | 99.83%-144K | ---- | -187.57%-82.74M | ---- | 686.23%94.48M | ---- | 55.42%-16.12M |
| -Other fair value changes | ---- | -11,210.42%-16.29M | ---- | 99.83%-144K | ---- | -187.57%-82.74M | ---- | 686.23%94.48M | ---- | 55.42%-16.12M |
| Asset sale loss (gain): | ---- | 93.74%-30.36M | ---- | -90.56%-484.65M | ---- | -9.57%-254.33M | ---- | -118.39%-232.12M | ---- | -43.36%-106.29M |
| -Loss (gain) from sale of subsidiary company | ---- | 93.32%-32.2M | ---- | -88.62%-482.09M | ---- | -9.93%-255.59M | ---- | -170.58%-232.51M | ---- | -7.70%-85.93M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 171.89%1.84M | ---- | -302.53%-2.56M | ---- | 221.37%1.26M | ---- | -90.73%393K | ---- | -19.67%4.24M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -6,747.03%-24.59M |
| Depreciation and amortization: | ---- | 21.76%892.73M | ---- | 23.82%733.16M | ---- | 21.16%592.12M | ---- | -8.82%488.71M | ---- | 6.98%536.01M |
| -Amortization of intangible assets | ---- | 0.00%97K | ---- | 0.00%97K | ---- | 0.00%97K | ---- | -53.37%97K | ---- | -34.80%208K |
| -Other depreciation and amortization | ---- | -1.72%-355K | ---- | 0.29%-349K | ---- | 81.62%-350K | ---- | -14.70%-1.9M | ---- | 16.33%-1.66M |
| Financial expense | ---- | 5.09%683.95M | ---- | 19.13%650.82M | ---- | 22.46%546.32M | ---- | 10.31%446.12M | ---- | 5.10%404.42M |
| Exchange Loss (gain) | ---- | 102.27%144K | ---- | 76.04%-6.35M | ---- | -2,064.54%-26.48M | ---- | 106.18%1.35M | ---- | -881.94%-21.82M |
| Special items | ---- | -56.53%5.82M | ---- | -54.68%13.38M | ---- | 232.38%29.52M | ---- | -41.49%8.88M | ---- | -24.22%15.18M |
| Adjustment items | ---- | -1.72%-355K | ---- | 0.29%-349K | ---- | 81.62%-350K | ---- | -14.70%-1.9M | ---- | 16.33%-1.66M |
| Operating profit before the change of operating capital | ---- | 19.18%2.2B | ---- | 2.66%1.84B | ---- | 18.20%1.8B | ---- | 2.38%1.52B | ---- | 12.06%1.49B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -301.80%-106.47M | ---- | 15.92%-26.5M | ---- | -98.82%-31.52M | ---- | -388.20%-15.85M | ---- | -143.15%-3.25M |
| Accounts receivable (increase)decrease | ---- | 43.73%-345.33M | ---- | -588.38%-613.66M | ---- | 88.19%-89.15M | ---- | 28.76%-754.54M | ---- | -4,111.36%-1.06B |
| Accounts payable increase (decrease) | ---- | -32.99%548.39M | ---- | 612.85%818.39M | ---- | -64.36%114.81M | ---- | -49.41%322.09M | ---- | 532.48%636.67M |
| prepayments (increase)decrease | ---- | 99.38%-2.22M | ---- | -152.91%-359.05M | ---- | 1,301.91%678.6M | ---- | 86.99%-56.46M | ---- | -465.71%-434.06M |
| Special items for working capital changes | ---- | -66.85%30.78M | ---- | 62.48%92.83M | ---- | -84.26%57.13M | ---- | -12.91%362.96M | ---- | 233.94%416.78M |
| Cash from business operations | 15.99%1.14B | 32.27%2.32B | 31.41%985.8M | -30.47%1.76B | -16.21%750.18M | 83.30%2.53B | 112.69%895.28M | 32.29%1.38B | 22.42%420.93M | 7.66%1.04B |
| Other taxs | 24.97%-102.56M | 24.50%-133.11M | -70.88%-136.7M | -38.93%-176.3M | -24.88%-80M | -68.71%-126.9M | -44.30%-64.06M | 2.29%-75.22M | -9.53%-44.4M | -141.73%-76.98M |
| Net cash from operations | 22.58%1.04B | 38.60%2.19B | 26.70%849.1M | -34.14%1.58B | -19.37%670.19M | 84.14%2.4B | 120.76%831.22M | 35.05%1.3B | 24.15%376.53M | 3.10%965.16M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 32.99%41.29M | ---- | 13.17%31.05M | ---- | 70.25%27.44M | ---- | 46.98%16.12M | ---- | 14.15%10.96M |
| Dividend received - investment | --29.34M | -16.06%48.33M | ---- | 6.63%57.58M | ---- | -41.13%54M | ---- | -54.29%91.72M | -50.95%83.02M | 3,348.01%200.67M |
| Decrease in deposits (increase) | -80.24%196.76M | 204.88%922.11M | 545.83%995.81M | -1,501.66%-879.22M | 50.89%-223.36M | 120.02%62.73M | -339.44%-454.77M | -69.78%-313.36M | -329.93%-103.49M | -41.59%-184.56M |
| Sale of fixed assets | ---- | -61.24%5.7M | ---- | 1,127.40%14.69M | ---- | 140.36%1.2M | ---- | -79.21%498K | ---- | -61.20%2.4M |
| Purchase of fixed assets | 37.17%-1.6B | -13.52%-4.26B | -32.72%-2.54B | 11.80%-3.75B | -48.94%-1.92B | -42.35%-4.25B | 4.14%-1.29B | -128.51%-2.99B | -141.80%-1.34B | -1.28%-1.31B |
| Purchase of intangible assets | 88.79%-16.9M | 44.66%-245.17M | -65.84%-150.67M | -305.39%-443.06M | -52.35%-90.85M | 29.35%-109.29M | -31.36%-59.64M | -25.19%-154.7M | 4.33%-45.4M | -25.22%-123.58M |
| Sale of subsidiaries | -37.48%60.73M | -79.51%76.9M | 21.65%97.14M | -48.31%375.3M | 317.64%79.86M | -48.74%726.1M | -97.83%19.12M | 13.59%1.42B | 296.70%882.9M | 180.70%1.25B |
| Acquisition of subsidiaries | ---- | ---23.75M | ---- | ---- | ---- | ---- | ---- | 99.92%-20K | ---- | ---23.73M |
| Recovery of cash from investments | -23.00%941.37M | -19.40%2.53B | -12.67%1.22B | -48.18%3.13B | -55.65%1.4B | 77.96%6.05B | 122.34%3.16B | -8.31%3.4B | -45.70%1.42B | 42.27%3.71B |
| Cash on investment | 41.27%-965.45M | 19.69%-2.51B | 3.79%-1.64B | 50.60%-3.13B | 49.42%-1.71B | -84.11%-6.33B | -140.68%-3.38B | 6.47%-3.44B | 46.05%-1.4B | -41.67%-3.68B |
| Other items in the investment business | 116.52%18.57M | ---- | -675.76%-112.38M | ---- | -166.18%-14.49M | ---- | 7,473.70%21.89M | 210.66%10.41M | -99.24%289K | 915.15%3.35M |
| Net cash from investment operations | 37.53%-1.33B | 25.49%-3.42B | 13.69%-2.14B | -21.63%-4.59B | -24.84%-2.47B | -92.47%-3.77B | -289.03%-1.98B | -1,265.26%-1.96B | -176.41%-509.59M | 85.88%-143.54M |
| Net cash before financing | 77.18%-293.67M | 59.18%-1.23B | 28.68%-1.29B | -119.23%-3.01B | -56.77%-1.8B | -109.00%-1.37B | -765.22%-1.15B | -179.87%-656.25M | -211.88%-133.06M | 1,119.99%821.62M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -29.16%3.18B | -18.41%6.44B | -3.66%4.49B | 84.78%7.9B | 110.61%4.66B | -18.71%4.27B | 98.00%2.21B | 111.36%5.26B | 141.79%1.12B | 34.46%2.49B |
| Refund | 26.55%-2.17B | -25.17%-4.83B | -16.33%-2.95B | -103.36%-3.86B | -168.86%-2.54B | -11.70%-1.9B | -64.16%-944.15M | -2.93%-1.7B | -29.54%-575.12M | -121.51%-1.65B |
| Issuance of bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --28.24M |
| Interest paid - financing | 1.56%-367.23M | 3.44%-708.25M | 1.00%-373.05M | -15.14%-733.44M | -19.98%-376.81M | -13.21%-637M | -4.62%-314.05M | 2.70%-562.67M | 0.10%-300.18M | -15.02%-578.27M |
| Dividends paid - financing | -244.64%-49.64M | -6.46%-324.77M | 38.17%-14.4M | -19.85%-305.06M | 11.95%-23.29M | -19.09%-254.52M | 87.53%-26.46M | -8.37%-213.73M | -3,297.23%-212.16M | -23.99%-197.22M |
| Absorb investment income | ---- | 54.22%89.98M | ---- | -63.59%58.35M | ---- | 2,410.75%160.26M | ---- | --6.38M | ---- | ---- |
| Issuance expenses and redemption of securities expenses | -375.91%-42.05M | 92.59%-68.12M | 98.54%-8.84M | -283.98%-919.45M | -2,759.71%-603.57M | 69.28%-239.45M | 97.23%-21.11M | -1,342.53%-779.56M | -2,241.87%-761.15M | 84.45%-54.04M |
| Other items of the financing business | -98.54%731K | 68.82%-46.63M | 152.16%50.01M | -27.55%-149.55M | -938.80%-95.88M | -9.60%-117.25M | 118.82%11.43M | -163.45%-106.98M | -227.18%-60.73M | -132.71%-40.61M |
| Net cash from financing operations | -55.48%527.49M | -73.40%525.04M | 16.70%1.18B | 54.52%1.97B | 10.97%1.02B | -32.45%1.28B | 214.89%914.83M | 12,584.85%1.89B | -185.53%-796.27M | -107.32%-15.15M |
| Effect of rate | 26.62%-4.39M | 37.21%10.65M | -145.78%-5.99M | -85.85%7.76M | 41.54%13.08M | 1,268.48%54.86M | 934.69%9.24M | 45.29%-4.7M | -128.79%-1.11M | -443.14%-8.58M |
| Net Cash | 328.29%233.82M | 32.03%-702.33M | 87.03%-102.42M | -995.90%-1.03B | -233.98%-789.62M | -107.64%-94.29M | 74.56%-236.43M | 53.10%1.23B | -481.03%-929.33M | 537.77%806.48M |
| Begining period cash | -28.28%1.75B | -29.55%2.45B | -29.55%2.45B | -1.12%3.47B | -1.12%3.47B | 53.94%3.51B | 53.94%3.51B | 53.82%2.28B | 53.82%2.28B | 9.53%1.48B |
| Cash at the end | -15.14%1.98B | -28.28%1.75B | -13.27%2.34B | -29.55%2.45B | -17.93%2.69B | -1.12%3.47B | 143.20%3.28B | 53.94%3.51B | 1.78%1.35B | 53.82%2.28B |
| Cash balance analysis | ||||||||||
| Cash and bank balance | -17.04%2.32B | -42.88%2.23B | -18.39%2.8B | -3.61%3.9B | --3.43B | -2.46%4.05B | ---- | 59.18%4.15B | 23.87%1.78B | 62.48%2.61B |
| Cash and cash equivalent balance | -15.15%3.97B | -30.74%3.39B | 77.89%4.67B | 20.79%4.89B | --2.63B | 15.35%4.05B | ---- | 53.94%3.51B | 33.97%1.78B | 53.82%2.28B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.